the Efficacy and Safety of Ondansetron Oral Soluble Pellicles

Phase 3 Unknown 184 enrolled The First Affiliated Hospital of Xinxiang Medical College

RandomizedParallel-groupSingle-blindTreatment

Summary

The name of this prospective study is a multicenter, open-label, randomized controlled clinical study of the efficacy and safety of Ondansetron Oral Soluble Pellicles for the prevention of delayed nausea and vomiting induced by highly emetogenic chemotherapy.

Timeline

Start: 2024-02-20
Primary completion: 2024-03-01
Completion: 2024-12-29

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ondansetron	Other / unclassified	8 mg	Oral

Indications

No indication recorded.